Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Ligands for Human IgG and Their Effector Functions
Steven W. de Taeye, Theo Rispens, Gestur Vidarsson
Antibodies (2019) Vol. 8, Iss. 2, pp. 30-30
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Tumor microenvironment complexity and therapeutic implications at a glance
Roghayyeh Baghban, Leila Roshangar, Rana Jahanban‐Esfahlan, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 1330
Maternal Immunological Adaptation During Normal Pregnancy
Bahaa Abu-Raya, Christina Michalski, Manish Sadarangani, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 429
FcγR Binding and ADCC Activity of Human IgG Allotypes
Steven W. de Taeye, Arthur E. H. Bentlage, Mirjam M. Mebius, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 142
Dengue Vaccines: An Update
Jesús Torres-Flores, Arturo Reyes‐Sandoval, Ma Isabel Salazar
BioDrugs (2022) Vol. 36, Iss. 3, pp. 325-336
Open Access | Times Cited: 89
Membranous nephropathy: new pathogenic mechanisms and their clinical implications
Elion Hoxha, Linda Reinhard, Rolf A.K. Stahl
Nature Reviews Nephrology (2022) Vol. 18, Iss. 7, pp. 466-478
Closed Access | Times Cited: 84
IgG glycans in health and disease: Prediction, intervention, prognosis, and therapy
Sofia Shkunnikova, Anika Mijakovac, Lucija Sironić, et al.
Biotechnology Advances (2023) Vol. 67, pp. 108169-108169
Open Access | Times Cited: 38
Impact of structural modifications of IgG antibodies on effector functions
Timon Damelang, Maximilian Brinkhaus, Thijs L. J. van Osch, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 30
Dengue Fever, COVID‐19 (SARS‐CoV‐2), and Antibody‐Dependent Enhancement (ADE): A Perspective
Henning Ulrich, Micheli Mainardi Pillat, Attila Tárnok
Cytometry Part A (2020) Vol. 97, Iss. 7, pp. 662-667
Open Access | Times Cited: 113
Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention
Dhavalkumar D. Patel, James B. Bussel
Journal of Allergy and Clinical Immunology (2020) Vol. 146, Iss. 3, pp. 467-478
Open Access | Times Cited: 96
The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies
Patricia Gogesch, Simone Dudek, Ger van Zandbergen, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8947-8947
Open Access | Times Cited: 84
Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid
Sharon Yehuda, Vered Padler‐Karavani
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 59
The Role of IgG4 in the Fine Tuning of Tolerance in IgE-Mediated Allergy and Cancer
Rodolfo Bianchini, Sophia N. Karagiannis, Galateja Jordakieva, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5017-5017
Open Access | Times Cited: 53
Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
Hilma J. van der Horst, Inger S. Nijhof, Tuna Mutis, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 3041-3041
Open Access | Times Cited: 53
Antibody dependent enhancement: Unavoidable problems in vaccine development
Lele Xu, Zhiqian Ma, Yang Li, et al.
Advances in immunology (2021), pp. 99-133
Open Access | Times Cited: 40
Afucosylated IgG responses in humans – structural clues to the regulation of humoral immunity
Janita J. Oosterhoff, Mads Delbo Larsen, C. Ellen van der Schoot, et al.
Trends in Immunology (2022) Vol. 43, Iss. 10, pp. 800-814
Open Access | Times Cited: 33
Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protection
Tyler Brady, Corinne Cayatte, Tiffany Barnes, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
The Influence of Human IgG Subclass and Allotype on Complement Activation
Timon Damelang, Steven W. de Taeye, Rosa Rentenaar, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 11, pp. 1725-1735
Open Access | Times Cited: 15
Immunoglobulin A response to SARS-CoV-2 infection and immunity
Khaleqsefat Esmat, Baban Jamil, Ramiar Kamal Kheder, et al.
Heliyon (2024) Vol. 10, Iss. 1, pp. e24031-e24031
Open Access | Times Cited: 5
Differential Serotype Specificity in the IgG Subclass Profile of the Anti‐Domain III Response Elicited by Dengue Virus Infection
Luis Gabriel González‐Lodeiro, Pedro Henrique da Conceição Roque, Neyda Hernández, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 3
Closed Access
Mechanisms of organ transplant injury mediated by B cells and antibodies: Implications for antibody-mediated rejection
Anita S. Chong
American Journal of Transplantation (2020) Vol. 20, pp. 23-32
Open Access | Times Cited: 48
Cross-reactivity of mouse IgG subclasses to human Fc gamma receptors: Antibody deglycosylation only eliminates IgG2b binding
A. Robin Temming, Arthur E. H. Bentlage, Steven W. de Taeye, et al.
Molecular Immunology (2020) Vol. 127, pp. 79-86
Open Access | Times Cited: 39
Antibody-Drug Conjugates: Functional Principles and Applications in Oncology and Beyond
Charalampos Theocharopoulos, Panagiotis-Petros Lialios, Michael Samarkos, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1111-1111
Open Access | Times Cited: 35
Immunomodulatory Properties of Immune Checkpoint Inhibitors—More than Boosting T-Cell Responses?
Michael Kuske, Maximilian Haist, T. Jung, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1710-1710
Open Access | Times Cited: 22
Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
Evi Struble, Jonathan Rawson, Tzanko S. Stantchev, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1538-1538
Open Access | Times Cited: 13
Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
Monika Žilková, Anna Nölle, Branislav Kováčech, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top